Factors Associated with the Use of Drug-Eluting Stents in Patients Presenting with Acute ST-Segment Elevation Myocardial Infarction

Background. Drug-eluting stents (DES) have proven clinical superiority to bare-metal stents (BMS) for the treatment of patients with ST-segment elevation myocardial infarction (STEMI). Decision to implant BMS or DES is dependent on the patient’s ability to take dual antiplatelet therapy. This study...

Full description

Bibliographic Details
Main Authors: Jose F. Chavez, Jacob A. Doll, Anuj Mediratta, Francesco Maffessanti, Janet Friant, Jonathan D. Paul, John E. A. Blair, Sandeep Nathan, Neeraj Jolly, Atman P. Shah
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2015/528753